175 related articles for article (PubMed ID: 20432235)
1. Generation of robust CD8+ T-cell responses against subdominant epitopes in conserved regions of HIV-1 by repertoire mining with mimotopes.
Schaubert KL; Price DA; Salkowitz JR; Sewell AK; Sidney J; Asher TE; Blondelle SE; Adams S; Marincola FM; Joseph A; Sette A; Douek DC; Ayyavoo V; Storkus W; Leung MY; Ng HL; Yang OO; Goldstein H; Wilson DB; Kan-Mitchell J
Eur J Immunol; 2010 Jul; 40(7):1950-62. PubMed ID: 20432235
[TBL] [Abstract][Full Text] [Related]
2. Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitope.
Schaubert KL; Price DA; Frahm N; Li J; Ng HL; Joseph A; Paul E; Majumder B; Ayyavoo V; Gostick E; Adams S; Marincola FM; Sewell AK; Altfeld M; Brenchley JM; Douek DC; Yang OO; Brander C; Goldstein H; Kan-Mitchell J
J Immunol; 2007 Jun; 178(12):7756-66. PubMed ID: 17548613
[TBL] [Abstract][Full Text] [Related]
3. Despite biased TRBV gene usage against a dominant HLA B57-restricted epitope, TCR diversity can provide recognition of circulating epitope variants.
Simons BC; Vancompernolle SE; Smith RM; Wei J; Barnett L; Lorey SL; Meyer-Olson D; Kalams SA
J Immunol; 2008 Oct; 181(7):5137-46. PubMed ID: 18802118
[TBL] [Abstract][Full Text] [Related]
4. Immunogenically optimized peptides derived from natural mutants of HIV CTL epitopes and peptide combinatorial libraries.
Blondelle SE; Moya-Castro R; Osawa K; Schroder K; Wilson DB
Biopolymers; 2008; 90(5):683-94. PubMed ID: 18481808
[TBL] [Abstract][Full Text] [Related]
5. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
Kan-Mitchell J; Bisikirska B; Wong-Staal F; Schaubert KL; Bajcz M; Bereta M
J Immunol; 2004 May; 172(9):5249-61. PubMed ID: 15100263
[TBL] [Abstract][Full Text] [Related]
6. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response.
Kan-Mitchell J; Bajcz M; Schaubert KL; Price DA; Brenchley JM; Asher TE; Douek DC; Ng HL; Yang OO; Rinaldo CR; Benito JM; Bisikirska B; Hegde R; Marincola FM; Boggiano C; Wilson D; Abrams J; Blondelle SE; Wilson DB
J Immunol; 2006 Jun; 176(11):6690-701. PubMed ID: 16709828
[TBL] [Abstract][Full Text] [Related]
7. Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.
Thorn M; Tang S; Therrien D; Kløverpris H; Vinner L; Kronborg G; Gerstoft J; Corbet S; Fomsgaard A
APMIS; 2007 Jun; 115(6):757-68. PubMed ID: 17550385
[TBL] [Abstract][Full Text] [Related]
8. Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine.
Singh RA; Wu L; Barry MA
J Immunol; 2002 Jan; 168(1):379-91. PubMed ID: 11751984
[TBL] [Abstract][Full Text] [Related]
9. Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL.
McKinney DM; Skvoretz R; Livingston BD; Wilson CC; Anders M; Chesnut RW; Sette A; Essex M; Novitsky V; Newman MJ
J Immunol; 2004 Aug; 173(3):1941-50. PubMed ID: 15265928
[TBL] [Abstract][Full Text] [Related]
10. Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection.
Lopes AR; Jaye A; Dorrell L; Sabally S; Alabi A; Jones NA; Flower DR; De Groot A; Newton P; Lascar RM; Williams I; Whittle H; Bertoletti A; Borrow P; Maini MK
J Immunol; 2003 Jul; 171(1):307-16. PubMed ID: 12817012
[TBL] [Abstract][Full Text] [Related]
11. Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes.
Corbet S; Nielsen HV; Vinner L; Lauemoller S; Therrien D; Tang S; Kronborg G; Mathiesen L; Chaplin P; Brunak S; Buus S; Fomsgaard A
J Gen Virol; 2003 Sep; 84(Pt 9):2409-2421. PubMed ID: 12917462
[TBL] [Abstract][Full Text] [Related]
12. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
[TBL] [Abstract][Full Text] [Related]
13. Repertoire and immunofocusing of CD8 T cell responses generated by HIV-1 gag-pol and expression library immunization vaccines.
Singh RA; Barry MA
J Immunol; 2004 Oct; 173(7):4387-93. PubMed ID: 15383568
[TBL] [Abstract][Full Text] [Related]
14. Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines.
Borthwick N; Lin Z; Akahoshi T; Llano A; Silva-Arrieta S; Ahmed T; Dorrell L; Brander C; Murakoshi H; Takiguchi M; Hanke T
PLoS One; 2017; 12(4):e0176418. PubMed ID: 28448594
[TBL] [Abstract][Full Text] [Related]
15. Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvant.
Korsholm KS; Karlsson I; Tang ST; Brandt L; Agger EM; Aagaard C; Andersen P; Fomsgaard A
PLoS One; 2013; 8(5):e63575. PubMed ID: 23691069
[TBL] [Abstract][Full Text] [Related]
16. Control of HIV-1 replication in vitro by vaccine-induced human CD8(+) T cells through conserved subdominant Pol epitopes.
Ahmed T; Borthwick NJ; Gilmour J; Hayes P; Dorrell L; Hanke T
Vaccine; 2016 Feb; 34(9):1215-24. PubMed ID: 26784683
[TBL] [Abstract][Full Text] [Related]
17. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
J Immunol; 2003 Nov; 171(10):5611-23. PubMed ID: 14607970
[TBL] [Abstract][Full Text] [Related]
18. Clonotypic architecture of a Gag-specific CD8+ T-cell response in chronic human HIV-2 infection.
Moysi E; Darko S; Gea-Mallorquí E; Petrovas C; Almeida JR; Wolinsky D; Peng Y; Jaye A; Stewart-Jones G; Douek DC; Koup RA; Dong T; Rowland-Jones S
Eur J Immunol; 2021 Oct; 51(10):2485-2500. PubMed ID: 34369597
[TBL] [Abstract][Full Text] [Related]
19. Broad TCR usage in functional HIV-1-specific CD8+ T cell expansions driven by vaccination during highly active antiretroviral therapy.
Yang H; Dong T; Turnbull E; Ranasinghe S; Ondondo B; Goonetilleke N; Winstone N; di Gleria K; Bowness P; Conlon C; Borrow P; Hanke T; McMichael A; Dorrell L
J Immunol; 2007 Jul; 179(1):597-606. PubMed ID: 17579081
[TBL] [Abstract][Full Text] [Related]
20. DNA Vaccination by Electroporation Amplifies Broadly Cross-Restricted Public TCR Clonotypes Shared with HIV Controllers.
Mukhopadhyay M; Galperin M; Patgaonkar M; Vasan S; Ho DD; Nouël A; Claireaux M; Benati D; Lambotte O; Huang Y; Chakrabarti LA
J Immunol; 2017 Nov; 199(10):3437-3452. PubMed ID: 28993513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
